- Home
- EEA vs OVID Comparison
EEA vs OVID Comparison
Compare EEA & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEA
- OVID
- Stock Information
- Founded
- EEA 1986
- OVID 2014
- Country
- EEA Germany
- OVID United States
- Employees
- EEA N/A
- OVID N/A
- Industry
- EEA Trusts Except Educational Religious and Charitable
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- EEA Finance
- OVID Health Care
- Exchange
- EEA Nasdaq
- OVID Nasdaq
- Market Cap
- EEA 57.7M
- OVID 47.1M
- IPO Year
- EEA N/A
- OVID 2017
- Fundamental
- Price
- EEA $8.99
- OVID $0.62
- Analyst Decision
- EEA
- OVID Strong Buy
- Analyst Count
- EEA 0
- OVID 6
- Target Price
- EEA N/A
- OVID $4.03
- AVG Volume (30 Days)
- EEA 9.2K
- OVID 470.8K
- Earning Date
- EEA 01-01-0001
- OVID 03-07-2025
- Dividend Yield
- EEA 1.92%
- OVID N/A
- EPS Growth
- EEA N/A
- OVID N/A
- EPS
- EEA N/A
- OVID N/A
- Revenue
- EEA N/A
- OVID $631,695.00
- Revenue This Year
- EEA N/A
- OVID $71.38
- Revenue Next Year
- EEA N/A
- OVID N/A
- P/E Ratio
- EEA N/A
- OVID N/A
- Revenue Growth
- EEA N/A
- OVID 113.21
- 52 Week Low
- EEA $7.45
- OVID $0.56
- 52 Week High
- EEA $9.26
- OVID $3.79
- Technical
- Relative Strength Index (RSI)
- EEA 64.38
- OVID 38.62
- Support Level
- EEA $8.97
- OVID $0.56
- Resistance Level
- EEA $9.15
- OVID $0.67
- Average True Range (ATR)
- EEA 0.11
- OVID 0.06
- MACD
- EEA 0.02
- OVID 0.00
- Stochastic Oscillator
- EEA 71.93
- OVID 35.94
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.